| Literature DB >> 35629340 |
Eui-Ho Park1,2, Nam-Soo Kim1,3, Yeon-Kyung Lee1, June-Seek Choi1.
Abstract
Accumulating evidence suggests that the medial prefrontal cortex (mPFC) has been implicated in the acquisition of fear memory during trace fear conditioning in which a conditional stimulus (CS) is paired with an aversive unconditional stimulus (UCS) separated by a temporal gap (trace interval, TI). However, little is known about the role of the prefrontal cortex for short- and long-term trace fear memory formation. Thus, we investigated how the prelimbic (PL) subregion within mPFC in rats contributes to short- and long-term trace fear memory formation using electrolytic lesions and d,l,-2-amino-5-phosphonovaleric acid (APV), an N-methyl-D-aspartate receptor (NMDAR) antagonist infusions into PL. In experiment 1, pre-conditioning lesions of PL impaired freezing to the CS as well as TI during the acquisition and retrieval sessions, indicating that PL is critically involved in trace fear memory formation. In experiment 2, temporary blockade of NMDA receptors in PL impaired the acquisition, but not the expression of short- and long-term trace fear memory. In addition, the inactivation of NMDAR in PL had little effect on locomotor activity, pre-pulse inhibition (PPI), or shock sensitivity. Taken together, these results suggest that NMDA receptor-mediated neurotransmission in PL is required for the acquisition of trace fear memory.Entities:
Keywords: N-methyl-D-aspartate (NMDA) receptors; prelimbic cortex; trace fear conditioning
Year: 2022 PMID: 35629340 PMCID: PMC9147616 DOI: 10.3390/life12050672
Source DB: PubMed Journal: Life (Basel) ISSN: 2075-1729
Figure 1Experimental schedules for conditioning and surgery with electrolytic lesions (1st) and drug injection (2nd).
Figure 2Electrolytic lesions and drug injection sites. (A) Reconstructions of the most extensive (gray) and least extensive (black) lesions in coronal section (bregma 2.7, 3.2, 3.7 and 4.2 mm) are illustrated. (B) Locations of cannula tip in coronal section (bregma 3.2, 3.7 and 3.70 mm) are marked in PL. Anterior extension of cingulate cortex area 1 (Cg1), prelimbic area (PL), infralimbic, medial orbitofrontal cortex (MO), artificial cerebrospinal fluid (aCSF), and DL-2-amino-5-phosphnovaleric acid (APV).
Figure 3Effects of PL lesion on conditioning and retention tests. (A) Freezing response to the conditional stimulus (CS) and trace interval (TI) between sham and PL-lesion groups during conditioning session. (B) Freezing response to the CS and TI during STM test. (C) Freezing response to the CS and TI during LTM test. Values are expressed as mean ± SEM. * p < 0.05 and ** p < 0.01 vs. Sham group.
Figure 4Effects of drug injection into PL on conditioning and retention tests. (A) Freezing response to the CS and TI between aCSF- and APV-treated groups before conditioning session. (B) Freezing response to the CS and TI between aCSF- and APV-treated groups before STM test. (C) Freezing response to the CS and TI between aCSF- and APV-treated groups before LTM test. Values are expressed as mean ± SEM. * p < 0.05 or ** p < 0.01 means a significant main effect of pre-conditioning drug infusion.